Central Pacific Bank Trust Division Regeneron Pharmaceuticals, Inc. Transaction History
Central Pacific Bank Trust Division
- $827 Billion
- Q3 2025
A detailed history of Central Pacific Bank Trust Division transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 1,432 shares of REGN stock, worth $993,092. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,432
Previous 1,157
23.77%
Holding current value
$993,092
Previous $607 Million
32.55%
% of portfolio
0.1%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...